Ambassador Intra (542524)
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹39.87 |
| Market Cap | ₹8.51 Cr |
| P/E Ratio | 61.94 |
| ROCE | 7.48% |
| ROE | 4.77% |
| Dividend Yield | 0% |
| Profit Growth | 1,000% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹32.76 — ₹50.36 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹16.14 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Ambassador Intra is the kind of microcap that tests a value investor's patience. At ₹39.87, the market cap is only ₹9 Cr, and the P/E is 61.94. Graham would never pay 62 times earnings for a trading and distribution company whose sales growth is zero. This is a business without a moat; distributors are price-takers, and customers have no loyalty. The balance sheet shows book value of ₹16.14, so the price-to-book is 2.47. That is expensive for a return on equity of just 4.77%. ROCE at 7.48% is not much better than a fixed deposit, and with no dividend, I am not being paid to wait. The 1,000% profit growth looks eye-catching, but I must be skeptical. The latest quarter shows sales of ₹2 Cr and net profit of ₹0 Cr. That means the profit growth is from an almost invisible base, not from a compounding franchise. The PEG ratio of 0.06 is only a reasonable summary of future expectations if the 1,000% growth continues, and with sales growth at zero, I see no evidence for that. The Piotroski F-score of 6/9 is a small positive, but it does not cure the valuation problem. I also have insufficient data on promoter holding and debt/equity, so I cannot fully assess governance and leverage. For me, the margin of safety lies in buying a good business at a fair price. This is a mediocre business at an unfair price. Mr. Market has not offered me a bargain; he has offered me a lottery ticket. I prefer to let this one pass.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer